Navigation Links
New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
Date:5/16/2008

the FDA of VELCADE and rituximab versus rituximab alone in patients with relapsed follicular lymphoma. Final data are expected in 2010. These trials support the Company's comprehensive development program in NHL.

About Multiple Myeloma

Multiple myeloma is the second most common hematologic malignancy and although the disease is predominantly a cancer of the elderly (the median age of onset is 70 years), recent statistics indicate both increasing incidence and younger age of onset. In the U.S., more than 50,000 individuals have MM and 20,000 new cases are diagnosed each year. Worldwide there are approximately 74,000 new cases and over 45,000 deaths annually.

About Non-Hodgkin's Lymphoma (NHL) and Mantle Cell Lymphoma (MCL)

NHL is the most common hematological cancer, the fifth leading cause of cancer death and the second fastest growing form of cancer in the U.S. The prevalence of NHL in the U.S. is approximately 400,000 patients, including approximately 200,000 patients with diffuse large B-cell lymphoma, 100,000 patients with follicular and marginal zone lymphoma and 10,000 with MCL. There are approximately 54,000 new cases of NHL diagnosed in the U.S. per year, and 19,000 deaths are attributed to the disease annually.

MCL is an aggressive, rapidly progressive subtype of NHL, and is not curable with standard treatment. The median life expectancy for a patient with MCL following first relapse is one to two years.

About VELCADE

VELCADE is being co-developed by Millennium Pharmaceuticals, The Takeda Oncology Company, and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Millennium is responsible for commercialization of VELCADE in the U.S. and Janssen-Cilag is responsible for commercialization in Europe and the rest of the world. Janssen Pharmaceutical K.K. is responsible for commercialization in Japan. For a limited period of time, Millennium and Ortho Biotech Inc. are co-promoting VELCADE in the U.S. VE
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents
2. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
3. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
4. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
5. More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL
6. Data Presented at AAN Support Potential for Adjunctive use of Intravenous Lacosamide as Short-Term Replacement for Oral Treatment in Partial Epilepsy
7. DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
8. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
9. Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women
10. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
11. Supportive Oncology Services Accrues One Million Cancer Patient Self-Reported Assessments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/7qs3dw/corporate ... Reputation of Pharma in 2014 - a Perspective of ... their offering. This independent study, funded by ... with an interest in diabetes on the corporate reputation ... industry as a whole) in 2014. The results from ...
(Date:4/17/2015)... April 17, 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), ... of innovative therapeutics for the treatment of cancer and ... presentation of data from three of its most advanced ... Research (AACR) 106 th Annual Meeting being held ... USA. The presentation on ...
(Date:4/16/2015)... , April 16, 2015  Hologic, Inc. (NASDAQ: ... cancer screening study i published on-line this ... journal of the American Cancer Society. ... the University of Pittsburgh Medical Center, supports current consensus guidelines ... that women 30-65 years of age be co-tested ...
Breaking Medicine Technology:Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4
... Clinical studies show Treximet provided significantly more patients ... relief compared to sumatriptan 85 mg, LONDON, April 15 ... (Nasdaq: POZN ) announced today that the FDA has,approved ... aura in adults. Treximet is the first and only migraine ...
... Summary: Genmab has,announced that HuMax-EGFr (zalutumumab) ... epidermal growth factor receptor (EGFr),molecules into a ... EGFr is central to its role in ... effective inhibition of cancer cell growth., ...
Cached Medicine Technology:Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 2Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 3Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 4Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 5Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 6Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 7Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS 2Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS 3
(Date:4/19/2015)... Insurancecarsinsurance.com has released a new blog post making ... weather can affect auto insurance premiums . ... auto insurance premiums. In some Northern states like Wisconsin, ... than in other parts. The newly released blog post ... several months and what impact, if any, it will ...
(Date:4/19/2015)... April 19, 2015 McCann Investigations, a ... announce the publication of white paper Married, but ... As online media provides a unique environment of ... market specifically targeting adulterous spouses has emerged. Social ... becomes as easy as shopping online. Dating sites ...
(Date:4/18/2015)... 2015 For some people, tattoos are works ... the rest of their lives, as they have spent a ... in a great amount of thought on their designs. For ... outgrown them or simply want them removed for personal or ... tattoo, and in 2012-13 there was a 43 percent increase ...
(Date:4/18/2015)... 2015 Carinsurancesavings.biz has released a new ... are cheaper during Spring. , Spring can be ... Drivers should make sure they compare the newest policies ... can learn more about Spring car insurance offers by ... insurance quotes are becoming more and more popular. Many ...
(Date:4/18/2015)... SMITHTOWN, NEW YORK (PRWEB) April 18, 2015 ... Inc. (AMO) are hosting a ‘Strategies for Success’ program ... & Refractive Surgeons meeting in San Diego, where eye ... ‘Distinguished Moderator’ for this invitation-only event. Dr. Martin is ... AMO and Review of Ophthalmology chose Dr. Martin to ...
Breaking Medicine News(10 mins):Health News:Bad Weather Can Cause Accidents and Affect Auto Insurance Prices! 2Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2Health News:Dennis Dass, M.D. is Shattering the Past While Revealing the Future 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2
... continued success, company offers new platform for general ... ... surgical device company, launched the TLS3 Tissue Ligating Shears,at the American ... With the introduction of this new platform, Starion is,building upon its ...
... at Event Dedicated to Women in New York City Living with ... ... Breast Cancer Network,(MBCN) today announced that October 13, 2007, has been ... Mayor Michael,Bloomberg. Metastatic Breast Cancer Awareness Day will be held in,conjunction ...
... Evaluation of ATIR by Dr. Velardi for ... Mismatched Bone Marrow Transplantation, AMSTERDAM, Netherlands, ... physician initiated European Phase II,clinical study for its lead product ... the successful treatment of,thirteen end stage blood cancer patients with ...
... inn and spa will open in late spring 2009, ... estate-style,inn, timeless in design and rising from a gentle ... accommodations in the Willamette,Valley,s famed pinot noir wine region, ... GGLO. A detailed description of the inn, spa, ...
... Oct. 9 Elvira, Mistress of the,Dark, will host ... party fundraiser benefiting AIDS Healthcare Foundation.,This wicked-cool event will ... in Hollywood at 6210 West Sunset Blvd. on Thursday, ... will feature a fashion show and contest,highlighting the unique ...
... 9 The Oregon Rehabilitation,Association (ORA), http://www.oregonrehabilitation.org, ... workers this October with National,Disability Employment Awareness Month. ... October to help increase the public,s awareness of,American ... the,entire month of October in 1988. This ...
Cached Medicine News:Health News:Starion Instruments Launches Next-Generation Tissue Ligating Shears at the American College of Surgeons Clinical Congress 2Health News:Mayor's Office Declares October 13 as First Metastatic Breast Cancer Awareness Day for New York City 2Health News:Mayor's Office Declares October 13 as First Metastatic Breast Cancer Awareness Day for New York City 3Health News:Kiadis Pharma Announces ATIR Interim Clinical Results 2Health News:Kiadis Pharma Announces ATIR Interim Clinical Results 3Health News:Details of Oregon Wine Region's First Luxury Inn, Spa Revealed at Groundbreaking Ceremony 2Health News:Details of Oregon Wine Region's First Luxury Inn, Spa Revealed at Groundbreaking Ceremony 3Health News:Details of Oregon Wine Region's First Luxury Inn, Spa Revealed at Groundbreaking Ceremony 4Health News:'Something Wicked!' This Way Comes: Elvira Hosts Halloween Fashion Show and Fundraiser Benefiting AIDS Healthcare Foundation 2Health News:October Is National Disability Employment Awareness Month 2
... ACS lenses offer the high resolution, high ... original clariVits. The simple two part design ... integrity during surgery. Simply autoclave, add saline ... lock together for use. (ACS) AutoClave Sterilizable ...
... highest magnification, indirect, contact, vitrectomy lens ... in the surgical management of macular ... in submacular surgery. The magnification of ... that of a plano/concave direct imaging ...
... MiniQuad XL is recommended for ... entire fundus and in the ... is the ideal lens for ... the operating microscope. It provides ...
... are now greatly improved with Volk's exclusive ... lens promotes precise and focused laser beam ... for enhanced viewing and laser treatment of ... comes standard with LaserWindow for optimal laser ...
Medicine Products: